Details

Autor(en) / Beteiligte

• Kiendrebeogo, Isabelle Touwendpoulimdé
• Zoure, Abdou Azaque
• Sorgho, Pegdwendé Abel
• Yonli, Albert Théophane
• Djigma, Florencia Wendkuuni
• Ouattara, Abdoul Karim
• Sombie, Herman Karim
• Tovo, Sessi Frida
• Yelemkoure, Edwige T.
• Bambara, Aboubacar Hierrhum
• Sawadogo, Alexis Yobi
• Bakri, Youssef
• Simpore, Jacques

Titel

Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina Faso

Ist Teil von

• Biomolecular concepts, 2019-11, Vol.10 (1), p.175-183

Ort / Verlag

Berlin: De Gruyter

Erscheinungsjahr

2019

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Abstract Background and objective Breast cancer remains the most common cause of cancer mortality in women. The aim of this study was to investigate associations between genetic variability in GSTM1 and GSTT1 and susceptibility to breast cancer. Methods Genomic DNA was extracted from blood samples for 80 cases of histologically diagnosed breast cancer and 100 control subjects. Genotyping analyses were performed by PCR-based methods. Associations between specific genotypes and the development of breast cancer were examined using logistic regression to calculate odds ratios [1] and 95% confidence intervals (95%CI). Results No correlation was found between GSTM1 - null and breast cancer (OR = 1.83; 95%CI 0.90-3.71; p = 0.10), while GSTT1 - null (OR = 2.42; 95%CI 1.17-5.02; p= 0.01) was associated with increased breast cancer risk. The GSTM1 / GSTT1 double null was not associated with an increased risk of developing breast cancer (OR = 2.52; 95%CI 0.75-8.45 ; p = 0.20) . Furthermore, analysis found no association between GSTM1 - null (OR =1.12; 95%CI 0.08-15.50; p = 1.00 ) or GSTT1 - null (OR = 1.71; 95%CI 0.13-22.51; p = 1.00 ) and the disease stage of familial breast cancer patients or sporadic breast cancer patients ( GSTM1 (OR = 0.40; 95%CI 0.12-1.32; p = 0.20 ) and GSTT1 (OR = 1.41; 95%CI 0.39-5.12; p = 0.75 )). Also, body mass index (BMI) was not associated with increased or decreased breast cancer risk in either GSTM1-null (OR = 0.60; 95%CI 0.21-1.68; p = 0.44) or GSTT1-null (OR = 0.60; 95%CI 0.21-1.68; p =0.45). Conclusion Our results suggest that only GSTT1-null is associated with increased susceptibility to breast cancer development.